Differential roles of insulin and IGF-1 receptors in adipose tissue development and function

Diabetes

Volumn 65, Issue 8, 2016, Pages 2201-2213

  Boucher, Jeremie ^a   Softic, Samir ^a,b   El Ouaamari, Abdelfattah ^a   Krumpoch, Megan T ^a   Kleinridders, Andre ^a   Kulkarni, Rohit N ^a   O'Neill, Brian T ^a   Kahn, C Ronald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADRB3 PROTEIN; ATGL PROTEIN; B LYMPHOCYTE GROWTH FACTOR; BETATROPHIN; CHOLESTEROL; CIDEA PROTEIN; CRE RECOMBINASE; DIO2 PROTEIN; ELOVL3 PROTEIN; FAS ANTIGEN; FAT DROPLET; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 4; HSL PROTEIN; INSULIN; INSULIN RECEPTOR; KI 67 ANTIGEN; LEPTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PRDM16 PROTEIN; PROTEIN; RESISTIN; SERPINB1 PROTEIN; SOMATOMEDIN C; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; UNINDEXED DRUG; SOMATOMEDIN C RECEPTOR; SUCCINATE DEHYDROGENASE;

ADIPOCYTE; AGE; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BROWN ADIPOSE TISSUE; CELL PROLIFERATION; CELL SIZE; CHOLESTEROL BLOOD LEVEL; COLD SENSITIVITY; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEART SIZE; HEART WEIGHT; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID STORAGE; LIPODYSTROPHY; LIVER; MALE; MOUSE; MUSCLE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; OXYGEN CONSUMPTION; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; POLYDIPSIA; PRIORITY JOURNAL; PROADIPOCYTE; SKELETAL MUSCLE; SKELETAL MUSCLE WEIGHT; UPREGULATION; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANIMAL; DRUG EFFECTS; GENETICS; IN VITRO STUDY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; RADIOIMMUNOPRECIPITATION;

ADIPOSE TISSUE; ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; IN VITRO TECHNIQUES; INSULIN; INSULIN-SECRETING CELLS; LEPTIN; LIPODYSTROPHY; MICE; MICE, KNOCKOUT; OXYGEN CONSUMPTION; RADIOIMMUNOPRECIPITATION ASSAY; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SUCCINATE DEHYDROGENASE;

EID: 84980328371     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0212     Document Type: Article

References (38)

1. Blüher S, Kratzsch J, Kiess W. Insulin-like growth factor I, growth hormone and insulin in white adipose tissue. Best Pract Res Clin Endocrinol Metab 2005; 19:577-587
2. Poulos SP, Hausman DB, Hausman GJ. The development and endocrine functions of adipose tissue. Mol Cell Endocrinol 2010;323:20-34
3. Boucher J, Tseng YH, Kahn CR. Insulin and insulin-like growth factor-1 receptors act as ligand-specific amplitude modulators of a common pathway regulating gene transcription. J Biol Chem 2010;285:17235-17245
4. Siddle K. Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances. Front Endocrinol (Lausanne) 2012; 3:34
5. Entingh-Pearsall A, Kahn CR. Differential roles of the insulin and insulin-like growth factor-I (IGF-I) receptors in response to insulin and IGF-I. J Biol Chem 2004;279:38016-38024
6. Blüher M, Michael MD, Peroni OD, et al. Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev Cell 2002;3:25-38
7. Guerra C, Navarro P, Valverde AM, et al. Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 2001;108:1205-1213
8. Klöting N, Koch L, Wunderlich T, et al. Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes 2008;57:2074-2082
9. Boucher J, Mori MA, Lee KY, et al. Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling. Nat Commun 2012;3:902
10. Lee KY, Russell SJ, Ussar S, et al. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes 2013;62:864-874
11. Jeffery E, Berry R, Church CD, et al. Characterization of Cre recombinase models for the study of adipose tissue. Adipocyte 2014;3:206-211
12. Eguchi J, Wang X, Yu S, et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab 2011;13:249-259
13. Mullican SE, Tomaru T, Gaddis CA, Peed LC, Sundaram A, Lazar MA. A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods. Mol Endocrinol 2013;27:127-134
14. El Ouaamari A, Kawamori D, Dirice E, et al. Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states. Cell Reports 2013;3:401-410
15. O'Neill BT, Lauritzen HP, Hirshman MF, Smyth G, Goodyear LJ, Kahn CR. Differential Role of Insulin/IGF-1 Receptor Signaling in Muscle Growth and Glucose Homeostasis. Cell Reports 2015;11:1220-1235
16. Debosch BJ, Chen Z, Saben JL, Finck BN, Moley KH. Glucose transporter 8 (GLUT8) mediates fructose-induced de novo lipogenesis and macrosteatosis. J Biol Chem 2014;289:10989-10998
17. Vernochet C, Damilano F, Mourier A, et al. Adipose tissue mitochondrial dysfunction triggers a lipodystrophic syndrome with insulin resistance, hepatosteatosis, and cardiovascular complications. FASEB J 2014;28:4408-4419
18. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73-76
19. Ebihara K, Ogawa Y, Masuzaki H, et al. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes 2001;50:1440-1448
20. Asilmaz E, Cohen P, Miyazaki M, et al. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 2004;113:414-424
21. Fiorenza CG, Chou SH, Mantzoros CS. Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol 2011;7:137-150
22. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic β cell proliferation. Cell 2013;153:747-758
23. Gusarova V, Alexa CA, Na E, et al. ANGPTL8/betatrophin does not control pancreatic beta cell expansion. Cell 2014;159:691-696
24. El Ouaamari A, Dirice E, Gedeon N, et al. SerpinB1 Promotes Pancreatic β Cell Proliferation. Cell Metab 2016;23:194-205
25. Softic S, Boucher J, Solheim MH, et al. Lipodystrophy due to adipose tissue-specific insulin receptor knockout results in progressive NAFLD. Diabetes 2016; 65:2187-2200
26. Zisman A, Peroni OD, Abel ED, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000;6:924-928
27. Pan DA, Lillioja S, Kriketos AD, et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 1997;46:983-988
28. Gavin JR 3rd, Roth J, Neville DM Jr, de Meyts P, Buell DN. Insulindependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci USA 1974;71:84-88
29. Shanik MH, Xu Y, Skrha J, Dankner R, Zick Y, Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 2008; 31(Suppl. 2):S262-S268
30. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270:26746-26749
31. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697-10703
32. Körner A, Wabitsch M, Seidel B, et al. Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun 2005;337: 540-550
33. Wang QA, Tao C, Gupta RK, Scherer PE. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med 2013;19: 1338-1344
34. He W, Barak Y, Hevener A, et al. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 2003;100:15712-15717
35. Jones JR, Barrick C, Kim KA, et al. Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 2005;102:6207-6212
36. Wang F, Mullican SE, DiSpirito JR, Peed LC, Lazar MA. Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ. Proc Natl Acad Sci USA 2013;110:18656-18661
37. Huang-Doran I, Sleigh A, Rochford JJ, O'Rahilly S, Savage DB. Lipodystrophy: metabolic insights from a rare disorder. J Endocrinol 2010;207:245-255
38. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002;109: 1345-1350